Saltar al contenido
Merck

Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.

Reviews in gastroenterological disorders (2009-11-10)
Danial E Baker
RESUMEN

Constipation is a common problem associated with opiates and opioid compounds used for the treatment of pain and other medical conditions, and can influence patient quality of life. Methylnaltrexone appears effective in the therapy of opioid-induced constipation and will be useful for patients failing to respond to traditional laxative regimens.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Methylnaltrexone bromide, ≥97% (HPLC)